A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

Researchers at McGill University have uncovered a surprising twist in how dopamine affects movement, overturning a ...

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how scientists think about Parkinson's disease treatments.

A MeiraGTx Holdings gene therapy for Parkinson’s disease has preliminary data from a small clinical trial showing the one-time treatment showed both safety and efficacy, results that lay the ...

A late-stage trial of Cerevel Therapeutic’s Parkinson’s disease drug showed a significant reduction in the time patients suffer from symptoms, the company said Thursday, the latest study indicating ...

A small feasibility study found that an implanted device regulated by the body's brain activity could provide continual and improved treatment for the symptoms of Parkinson's disease (PD) in certain ...

Explore dopamine's role in movement and how it challenges long-standing theories about motor control and Parkinson's disease treatments.

IRLAB receives approval for phase Ib study with IRL757 in Parkinson’s disease: Gothenburg, Sweden Friday, December 26, 2025, 17:00 Hrs [IST] Sweden headquartered IRLAB, a compan ...

"That could change things for me because I'm not really getting the treatment that I should be getting," Rachel Reid ...

Researchers estimate that 89% of people with Parkinson's disease (PD) have speech and voice disorders including disorders of laryngeal, respiratory and articulatory function. Despite the high ...